Population	No. of deaths		Hazard ratio (95% CI)	p-value	p-value for heterogeneity*
	Tamoxifen	Placebo
All patients (ITT)	XX/XX	XX/XX	X.XX (X.XX, X.XX)	X.XX
Per protocol populations	XX/XX	XX/XX	X.XX (X.XX, X.XX)	X.XX
HIV status- Infected - Uninfected	XX/XX XX/XX	XX/XX XX/XX	X.XX (X.XX, X.XX) X.XX (X.XX, X.XX)	X.XX X.XX	X.XX
Baseline quantitative fungal count - <5 log10 CFU/ml - ≥5 log10 CFU/ml	XX/XX XX/XX	XX/XX XX/XX	X.XX (X.XX, X.XX) X.XX (X.XX, X.XX)	X.XX X.XX	X.XX